baber/WOPTO huggingface dataset:
Patent EP-1748734-B1 (EP)
Inventor: VAN FURTH WOUTER
IPC: A61B17/30
Filed: 2005-03-29
Granted: 2008-01-16
Abstract: The invention relates to a surgical instrument, e.g., forceps, and method to be used for suturing tissue, the surgical instrument comprising a first arm and a second arm that are spring-connected at a proximal end, while at a distal end the first arm and the second arm can be move towards each other, and wherein at least the first arm and/or the second arm can be provided with a flexible body that is suitable for receiving and affixing a surgical needle, wherein the flexible body is designed for being positioned at the distal end, at an inside and/or lower side of the end of an arm.
Patent EP-1876018-B1 (EP)
Inventor: ASABA TAKAO
IPC: B32B27/18
Filed: 2005-04-12
Granted: 2011-08-17
Abstract: There is provided an all-weather radio wave reflector/absorber capable of smoothly attenuating hazardous radio waves from microwave to millimetric wave of 400 MHz-100 GHz generated from various electric apparatuses and eliminating affect on human body or other electronic apparatus. The all-weather radio wave reflector/absorber includes a surface radio wave absorber (1) containing conductive granular material such as carbon particles (7) and ferrite particles in a continuous foamed portion (2) of only irregular foam or planar foam, an intermediate planar radio wave absorber (3) containing conductive granular material such as carbon particles (7) and ferrite particles in one layer or more of continuous foamed portion (2) of foam, and a thin layer of bottom face radio wave reflecting material (4) which are overlaid in layers and entirely wrapped up in a soft cloth so that radio waves from all directions can be absorbed, attenuated, reflected on the bottom face radio wave reflecting material (4) and absorbed by the absorber, and static electricity stored on the human body and clothes can be discharged.
Patent EP-1747664-B1 (EP)
Inventor: NIELSEN JAN ERNST
IPC: H04N1/10
Filed: 2005-04-26
Granted: 2009-01-21
Abstract: Disclosed is an apparatus for scanning a surface with electromagnetic radiation. The apparatus comprises a base plate for supporting a medium said medium having a scanning surface to be scanned, an optical head unit adapted to scan the scanning surface with electromagnetic radiation propagating along an optical axis, a fluid film generation unit connected to the optical head unit and adapted to generate a fluid film between the scanning surface and a gliding surface of the fluid film generation unit for maintaining a predetermined distance between the gliding surface and the scanning surface during scanning operation of the optical head unit across the scanning surface, and control means for controlling the position of the fluid film relative to the optical axis.
Patent EP-1771259-B1 (EP)
Inventor: STOCKTON JOHN H
IPC: A47L9/24
Filed: 2005-05-10
Granted: 2008-11-12
Abstract: A retractable hose extension for a vacuum having an expandable hose within a containment structure, a first coupling at the first end of the hose and in the first end of the containment structure for connecting the hose to a vacuum, a valve at the second end of the hose, and either a door or other releasable retention device for the hose. Preferably, the valve is an iris valve. Two fixed embodiment and one portable embodiment exist. The first fixed embodiment is inserted within a wall. The second fixed embodiment is rotatably attached to a tube contained within or running below a ceiling and extending from a vacuum system.
Patent EP-1761686-B1 (EP)
Inventor: JANAK ROBB
IPC: F01L9/10
Filed: 2005-05-06
Granted: 2012-08-08
Abstract: L'invention concerne des systèmes et des procédés permettant d'actionner des soupapes de moteur. Ces systèmes peuvent comporter des culbuteurs primaire et auxiliaire disposés adjacents l'un par rapport à l'autre sur un axe de culbuteur. Ledit culbuteur primaire permet d'actionner une soupape de moteur en vue des déplacements par actionnement de la soupape primaire, tels que l'échappement principal, en réponse à une entrée provenant d'une première soupape d'échappement, telle qu'une came. Ledit culbuteur auxiliaire permet de recevoir au moins un déplacement d'actionnement de soupape auxiliaire, tel que le freinage moteur, la recirculation de gaz d'échappement et/ou la recirculation de gaz de freinage à partir d'un second élément de soupape d'échappement. Un piston à actionnement hydraulique peut être placé entre le culbuteur auxiliaire et le culbuteur primaire. Ledit piston d'actionnement peut être sélectivement verrouillé en position d'extension entre les culbuteurs primaire et auxiliaire, de manière à transférer sélectivement les déplacements de l'actionnement de la soupape auxiliaire du culbuteur auxiliaire au culbuteur primaire.
Patent EP-1763538-B1 (EP)
Inventor: PENN MARC S
IPC: A61K35/545
Filed: 2005-05-17
Granted: 2010-08-25
Abstract: An isolated mesenchymal stem cell, multipotent adult progenitor cell, or other stem cells is genetically modified to express at least one of CXCR4, SDF-1, or a variant thereof.
Patent EP-1773630-B1 (EP)
Inventor: ROUX JEAN-PIERRE
IPC: B60R21/34
Filed: 2005-05-12
Granted: 2007-12-19
Abstract: The invention relates to a force evaluating device (18) comprising an impact discrimination means. A bumper (10) comprises a deformable energy absorber (14) consisting of at least one wall (17) compressed in the case of an impact and a groove (22) which has a given depth and arranged in or in front of said wall (17) of the absorber (14). The inventive device (18) also comprises a force sensor (20) which is placed in the groove (22, 26, 28) and embodied in the form of a binary sensor, i.e. it produces a signal when the force applied thereto is greater than a predetermined threshold and means (24) for compensating groove (22, 26, 28) when said depth is reduced by the low or high temperature of the bumper (10).
Patent EP-1792197-B1 (EP)
Inventor: KOSTANIC IVICA
IPC: G10L21/028
Filed: 2005-09-23
Granted: 2010-08-04
Abstract: A communications device for separating source signals provided by M signal sources includes an antenna array comprising N antenna elements for receiving at least N different summations of the M source signals. A code despreader is connected to the N antenna elements for decoding the at least N different summations of the M source signals. Each one of the N different summations includes k codes for providing k different summations of the M source signals associated therewith. A blind signal separation processor forms a mixing matrix comprising at least kN different summations of the M source signals, and separates desired source signals from the mixing matrix. The mixing matrix has a rank equal up to kN.
Patent EP-1813057-B1 (EP)
Inventor: STINEMAN JON ARTHUR JR
IPC: H04L12/10
Filed: 2005-10-20
Granted: 2010-02-24
Abstract: A power management mechanism for a multi-port IEEE 802.3af-compliant Power Sourcing Equipment (PSE) device supplying power to multiple links. The power management mechanism has an analog bus shared by PSE controllers for receiving current proportional to amount of power demanded by a respective link. A comparator associated with a PSE controller compares a bus voltage proportional to a total amount of power demanded from the system with a predetermined value indicating the maximum power demand that can be supported by the controller, in order to determine whether to provide power to a newly detected Powered Device (PD) requesting power. The PSE controller provides the PD with a demanded amount of power if the voltage of the bus does not exceed the predetermined value, and denies a request of the PD for power if the voltage exceeds the predetermined value.
Patent EP-1853921-B1 (EP)
Inventor: LENZ HELMUT
IPC: G01N33/68
Filed: 2005-12-22
Granted: 2011-03-23
Abstract: The present invention relates to the field of therapeutic antibodies. It especially relates to the study of therapeutic antibodies in an experimental animal. The present invention discloses a method of detecting a therapeutic antibody in a sample obtained from an experimental animal comprising the steps of a) providing the sample to be analyzed, b) incubating said sample with an antibody binding to a therapeutic antibody and not binding to the immunoglobulin of said experimental animal, c) optionally incubating said sample with a reagent appropriate for the selective detection of total, active or antigen-bound therapeutic antibody, and d) correlating the complex formed in (b) or (c) to the concentration of said therapeutic antibody.
Patent EP-1808009-B1 (EP)
Inventor: STATON HOUSTON
IPC: H04W4/90
Filed: 2005-10-20
Granted: 2011-01-19
Abstract: A method and system of selectively communicating with a first portable device within pre-defined geographical zones is disclosed. The first portable device is associated with a geographical zone defined utilizing latitude and longitude attributes. Data representative of the geographical zone is then loaded on the first portable device. The first portable device includes a ground positioning unit receiver which allows the first portable device to receive positioning data and to determine its position in relation to the geographical zone. When the first portable device determines it is within the geographical zone, the first portable device enables communication between the first portable device and a second portable device.
Patent EP-1846370-B1 (EP)
Title: 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES
Inventor: DELUCA HECTOR F
IPC: A61P11/06
Filed: 2005-11-18
Granted: 2010-06-02
Abstract: This invention discloses 17,20(Z)-dehydro vitamin D analogs, and specifically 17(Z)-1α,25-dihydroxy-17(20)-dehydro-2-methylene-19-nor-vitamin D3 and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also may be used to treat autoimmune disorders and inflammatory diseases in humans as well as renal osteodystrophy and obesity. This compound also has significant calcemic activity making it a therapeutic agent for the treatment or prophylaxis of osteoporosis, osteomalacia, renal osteodystrophy and hypoparathyroidism.
Patent EP-1760033-B1 (EP)
Inventor: MERIN PETER
IPC: B66F9/18
Filed: 2006-09-05
Granted: 2010-11-03
Abstract: Load handling apparatus and method for handling loads, like paper rolls or household appliances, wherein the load handling apparatus comprises a vehicle (1) with a hydraulic system (76) controlled by an electronic control system (77), a lifting means (1), a hydraulics user interface (78) for the operator and a gripper arranged in the vehicle's lifting means (11) and provided with arms (6, 7) capable of clamping and lifting a load by applying a compressive force to the load, wherein the gripper is provided with an electric or electronic control system (80), and wherein the gripper's control system is directly connected to the vehicle's hydraulics control system (77) or hydraulics user interface (79) through an electronic interface (73, 90) so that the gripper's control system is capable of controlling the vehicle's hydraulic functions in a similar way as the vehicle's operator using the vehicle's hydraulics user interface (78).
Patent EP-1738989-B1 (EP)
Inventor: ARLT GEORGE E
IPC: B62D3/12
Filed: 2006-06-14
Granted: 2009-02-11
Abstract: The invention provides for a power steering apparatus (30) comprising of a housing (32) that extends along a longitudinal axis (42). A rack (34) is disposed within the housing (32) and supported for movement along the longitudinal axis (42) by a bearing (40). A pinion (36) supported by the housing (32) is in meshing engagement with the rack (34). The bearing (40) disposed around the rack (34) includes a wall (66) of a continuous varying radial thickness that circumferentially surrounds the rack (34). An adjustment device (38) supported by the housing (32) is connected to the bearing (40) and rotatably adjusts the bearing (40) relative to the longitudinal axis (42). The continuous varying radial thickness of the wall (66) positions the rack (34) as the bearing (40) is rotated by the adjustment device (38) relative to the pinion (36) ensuring proper meshing engagement between the rack (34) and the pinion (36).
Patent EP-1731726-B1 (EP)
Inventor: CREHAN GABRIEL
IPC: F01M11/03
Filed: 2006-06-07
Granted: 2011-01-05
Abstract: The system has spherical or round shaped traps for sub-micron particles, where the traps are placed in a case next to an oil filter and are in contact with a lubricating oil of an engine of a motor vehicle. The traps integrate magnetic units and have a diameter between 1 mm and 20 mm. The traps are constituted of a porous material chosen from a metal, metal oxide, organic or inorganic polymer, ceramics, glass and graphite. The traps have pores whose diameters are lesser than 5 mu m.
Patent EP-1898171-B1 (EP)
Inventor: STADLER KONRAD
IPC: F27B7/42
Filed: 2006-09-11
Granted: 2009-08-19
Abstract: This object is achieved using an existing water injecting technology used in precalciners for NO x  control. The inventive method comprises the step of injecting water into the precalciner to control the temperature.  Thanks to considerably different time horizons of the NO x  control on one side and the temperature control on the other side, the two objectives can be achieved in parallel. The short term variations on the water injection for temperature control purposes are superposed to the long term water injections necessary to provide appropriate NO x  control.
Patent EP-1842202-B1 (EP)
Inventor: HOCHULI MARTIN
IPC: G11B33/02
Filed: 2006-01-19
Granted: 2011-05-25
Abstract: The invention relates to a case (6) for essentially rectangular memory cards (1), which are suitable for the long-term archiving of data, said case (6) housing at least 3 memory cards (1) and protecting them against vibration and damage. A case of this type (6) has dimensions complying to the norms that are prevalent in standard containers. In particular, the case (6) has the form and dimensions of a diskette, CD or DVD, CD case or case insert, cigarette packet, diskette box or film container.
Patent EP-1848426-B1 (EP)
Inventor: WUELFERT ERNST
IPC: A61P9/10
Filed: 2006-02-02
Granted: 2012-08-01
Abstract: L'invention porte sur des composés représentés par la formule (I) dans laquelle X est un groupe représenté par la formule >CR1R2 or >SO2; Y est un groupe représenté par la formule >NH ou >CR1R2; Z est un groupe représenté par la formule >C=O ou >CH2 ou une liaison directe; R1 est hydrogène et R2 est hydrogène, carboxy ou hydroxy; ou R1 et R2 représentent ensemble un groupe oxo, un groupe méthylènedioxy ou un groupe hydroxyimino; R3 est hydrogène ou un alkyle inférieur ; R4 représente deux atomes d'hydrogène, ou un groupe oxo ou hydroxyimino; R5 est hydrogène, alkyle inférieur ou halogène ; R6 est hydrogène, alkoxy inférieur ou carboxy; R7 et R8 sont chacun hydrogène, alkyle inférieur ou halogène; ainsi que sur des sels et des esters pharmaceutiquement acceptables de ceux-ci pouvant être utilisés pour le traitement ou la prophylaxie de maladies ou de conditions neurodégénérescentes aiguës ou chroniques telles que la maladie d'Alzheimer, la maladie de Parkinson, la chorée de Huntington, la sclérose en plaques ou les séquelles d'événements ischémiques aigus tels que les attaques cardiaques, les infarctus, les blessures à la tête, et pour la protection contre des dommages ischémiques atteignant les tissus des organes périphériques.
Patent EP-1864994-B1 (EP)
Inventor: ISHIWATA HIROYUKI
IPC: C07K5/10
Filed: 2006-03-29
Granted: 2011-10-26
Abstract: A pharmaceutical composition for the prevention/treatment of a disease associated with PAR-2 which comprises a compound represented by the general formula (1) below or a salt thereof or a solvate thereof and a pharmaceutically acceptable carrier; a method for prevention or treatment of a disease associated with PAR-2 by using the compound or salt thereof or solvate thereof; and use of the compound or salt thereof or solvate thereof in the preparation of the pharmaceutical composition: Ar-CO-AA1-AA2-AA3-AA4-NH-X-Y (1) wherein: Ar represents a phenyl or aromatic heterocyclic group which may have a substituent; AA1 represents a hydrophobic amino acid; AA2 represents an amino acid which does not have a substituent carrying 2 or more carbon atoms; AA3 represents an amino acid which does not have a substituent carrying 2 or more carbon atoms; AA4 represents a basic amino acid; X represents a divalent, straight-chain or branched saturated aliphatic hydrocarbon group having 1 to 6 carbon atoms; and Y represents a basic substituent, a straight-chain, branched or cyclic saturated aliphatic hydrocarbon group having 1 to 6 carbon atoms, or an aromatic hydrocarbon group having 6 to 10 carbon atoms. The compound represented by the general formula (1) has a remarkably improved PAR-2 activating ability compared to a peptide composed of six amino acid residues (tethered receptor agonist peptide: TRAP) in spite of the fact that the compound has a fewer number of constituent amino acid residues than TRAP.
Patent EP-1850851-B1 (EP)
Inventor: GANGJEE ALEEM
IPC: A61K31/135
Filed: 2006-01-23
Granted: 2011-09-07
Abstract: A compound having the following formula:   
wherein X is selected from the group consisting of a C1 to C6 alkyl group, a heteroalkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, an arylalkyl group, and a heteroarylalkyl group; 
wherein R 1  is selected from the group consisting of hydrogen, a C1 to C6 alkyl group, a heteroalkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, an arylalkyl group, and a heteroalkyl group; 
wherein R 2  is selected from the group consisting of hydrogen, a C1 to C6 alkyl group, a plurality of C1 to C6 alkyl groups, a heteroalkyl group, a plurality of heteroalkyl groups, an alkoxy group, a plurality of alkoxy groups, a substituted or unsubstituted aryl group, a plurality of substituted or unsubstituted aryl groups, a substituted or unsubstituted heteroaryl group, and a plurality of substituted or unsubstituted heteroaryl groups; 
wherein R 3  is selected from the group consisting of zero, a C1 to C6 alkyl group, a heteroalkyl group, an alkenyl group, and a heteroalkenyl group; and 
wherein R 4  is selected from the group consisting of a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, an arylalkyl group, a heteroarylalkyl group, and hydrogen, and R 4  is hydrogen when R 3  is zero, for use in a method of treating cancer by inhibiting mitosis, wherein said cancer is optionally one selected from: 
melanoma, leukemia, colon cancer, prostate cancer, lung cancer, pancreatic cancer, ovarian cancer, renal cancer, breast cancer, brain cancer, and Kaposi's sarcoma cancer.
Patent EP-1846226-B1 (EP)
Inventor: CHEICH ROBERT C
IPC: B65D65/40
Filed: 2006-01-26
Granted: 2009-07-22
Abstract: Cette invention concerne un procédé permettant de fabriquer un produit de rembourrage (94) à partir d'une longueur continue d'un matériau de base (92) comportant un matériau cohésif sur au moins une de ses surfaces, lequel procédé consiste à convertir le matériau de base en une configuration relativement moins dense dans laquelle au moins deux parties cohésives du matériau de base sont fixées l'une à l'autre.
Patent EP-1896652-B1 (EP)
Inventor: BYFELDT TOBIAS
IPC: D21F1/00
Filed: 2006-04-13
Granted: 2011-06-08
Abstract: A fabric and a method of forming a fabric formed by the steps of providing an endless fabric having at least two layers of MD yarns, raveling CD yarns in an area of said endless fabric to be cut, cutting at least one layer of MD yarns at a first predetermined location, and cutting at least one layer of MD yarns at a second predetermined location. The method also includes steps of folding the endless fabric in half in the MD direction, placing the first and second predetermined locations proximally to one another, forming loops from at least one uncut layer of MD yarns when said fabric is folded, and seaming the loops to form an endless fabric.
Patent EP-1882075-B1 (EP)
Inventor: LAMPERT RICO
IPC: E05F15/10
Filed: 2006-04-25
Granted: 2013-12-18
Abstract: A drive unit, in particular for adjusting movable parts in a motor vehicle, has a housing including an opening to the surrounding, in which a gas-permeable, liquid-impermeable diaphragm is installed, the housing includes a first housing part with a circumferential collar, and a second housing part which closes off the first housing part, on the second housing part the opening is integrally formed with a circumferential mating surface, which presses the diaphragm against the collar of the first housing part after the housing is closed, and a sealing element located between the diaphragm and the mating surface is integrally non-detachably formed on the first and/or second housing part.
Patent EP-2047718-B1 (EP)
Inventor: HENGER ULRICH
IPC: F21Y101/00
Filed: 2006-07-28
Granted: 2011-03-02
Abstract: High-pressure discharge lamp, with an outer bulb (10), on which a first terminal (12) and a second terminal (14) are provided, and with a discharge vessel (16), which is accommodated in the outer bulb (10), with a first and a second terminal (18, 20) and with an ignition apparatus (22), which is accommodated in the outer bulb (10) and is connected between the first terminal (12) of the outer bulb and the first terminal (18) of the discharge vessel (16). A switch (32), which closes depending on temperature, is connected in parallel with the ignition apparatus (22) between the first terminal (12) of the outer bulb (10) and the first terminal (18) of the discharge vessel (16). During operation of the lamp, the current therefore flows past the spiral pulse generator (32), so that no power is lost.
Patent EP-1901791-B1 (EP)
Inventor: BERNARDINI NUNZIA
IPC: A61L27/28
Filed: 2006-06-16
Granted: 2012-08-15
Abstract: L'invention concerne une composition biocompatible utilisée pour remplacer/régénérer des tissus articulaires, notamment des tissus du nucleus pulposus, mais également des tissus non articulaires, tels que des tissus osseux, pour préparer une matrice d'hydrogel comprenant un premier et un second polymère naturel, des cellules adaptées pour régénérer le tissu du centre d'un noyau de disque, un agent de réticulation adapté pour réticuler au moins un desdits polymères in situ, ce qui confère une résistance appropriée à la composition biocompatible, ainsi que des molécules adaptées pour stimuler la croissance et/ou la différenciation de cellules, un des deux polymères naturels étant de l'alginate de sodium. Dans un exemple particulier, la composition décrite ci-dessus présente, avant l'étape de la réticulation. une densité initiale lui permettant d'être injectée. En particulier l'action de réticulation sur l'alginate de sodium est induite par un agent de réticulation contenu dans des particules polymères biodégradables, libérées de manière régulée à partir de polymères naturels, par exemple de la gélatine, ou sur la base de polymères synthétiques, par exemple de l'acide polylactique ou de copolymères d'acide lactique-d'acide glycolique.
Patent EP-1968538-B1 (EP)
Inventor: KELLER MANFRED
IPC: A61K9/00
Filed: 2006-11-29
Granted: 2012-04-25
Abstract: The invention relates to liquid pharmaceutical compositions containing: a) a therapeutically effective dose of a cyclosporin; b) an aqueous carrier liquid; c) a first solubilizing substance selected among the group of phospholipids; and d) a second solubilizing substance selected among the group of non-ionic surfactants. Preferably, the cyclosporin is liposome solubilized. The inventive composition is suitable for oral, parenteral, nasal, mucosal, topical, and particularly pulmonary application in the form of an aerosol.